March 3, 2024
March is Autoimmune and MS Awareness Month: 12 Strategies to Help YOU Get a Better Night’s Sleep
- /
By Cathy Chester on March 1, 2024 — An Empowered Spirit, MS Patient Advocate Every month of the year seems designated as the month to…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
March 3, 2024
FLORIDA’S TOP 10 WHEELCHAIR ACCESSIBLE DESTINATIONS FOR TOURISTS & RESIDENTS ALIKE
- /
Year Round, the sunny State of Florida has a lot to offer wheelchair users, from plenty of wheelchair accessible van…
March 3, 2024
Disabled Travel: 19 Tips and Advice for Disabled Travelers
- /
Monday, May 6, 2019 Traveling with a disability is completely possible. With some planning and organizing, you can take that…
March 3, 2024
Exploring Disney with a Disability
- /
- /
Disabilities at Disney – Written by: Antoinette Yagy – owner of Free Wheeling Travel, LLC (a Facebook url) One of…
February 27, 2024
Will Frexalimab replace the anti-CD20s?
- /
- /
It is clear to me, and it should be clear to my colleagues, that anti-CD20 therapies have a limited shelf-life…
February 26, 2024
High incidence, prevalence of pediatric-onset MS in Sweden
- /
by Andrea Lobo, PhD | February 26, 2024 Sweden has a consistently high incidence and prevalence of pediatric-onset multiple sclerosis (PoMS), according to a recently…
February 26, 2024
Dark rim on MS lesions seen with standard MRI may mark activity
- /
- /
- /
Possible way of spotting in clinic rim lesions known to drive progression By Marisa Wexler, MS on 02/26/2024 An imaging…
February 19, 2024
New Free Workshop – Trevor Wicken is doing Hip Flexors
- /
CLICK here to learn more of the exciting Free Workshop…
February 16, 2024
MS trial to test magnetic brain stimulation for overactive bladder
- /
Texas site now enrolling 29 women with MS and urinary tract problems Steve Bryson, PhD avatarby Steve Bryson, PhD |…
February 15, 2024
Press Release: Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS (sanofi.com)
- /
- /
Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS Paris, February 15, 2024. The…
